Compare NSA & GRDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NSA | GRDN |
|---|---|---|
| Founded | 2013 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Retail-Drug Stores and Proprietary Stores |
| Sector | Real Estate | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 1.7B |
| IPO Year | 2015 | 2024 |
| Metric | NSA | GRDN |
|---|---|---|
| Price | $33.88 | $26.92 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 8 | 3 |
| Target Price | $32.50 | ★ $33.33 |
| AVG Volume (30 Days) | ★ 1.5M | 287.0K |
| Earning Date | 02-25-2026 | 11-10-2025 |
| Dividend Yield | ★ 6.80% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.61 | 0.28 |
| Revenue | $741,511,000.00 | ★ $1,389,638,000.00 |
| Revenue This Year | N/A | $19.50 |
| Revenue Next Year | $1.11 | $0.48 |
| P/E Ratio | ★ $55.12 | $105.82 |
| Revenue Growth | N/A | ★ 18.68 |
| 52 Week Low | $27.43 | $17.78 |
| 52 Week High | $40.62 | $37.43 |
| Indicator | NSA | GRDN |
|---|---|---|
| Relative Strength Index (RSI) | 80.17 | 32.27 |
| Support Level | $31.02 | $30.17 |
| Resistance Level | $32.24 | $31.90 |
| Average True Range (ATR) | 0.89 | 1.42 |
| MACD | 0.61 | -0.38 |
| Stochastic Oscillator | 99.46 | 0.40 |
National Storage Affiliates Trust Trust is a real estate investment trust. The company owns, operates, and acquires self-storage properties located within the metropolitan statistical areas throughout the United States. With the help of property management platform, the company manages and controls the day-to-day operations and affairs of consolidated properties and unconsolidated real estate ventures under the iStorage, SecurCare, RightSpace, Northwest and Move It brands.
Guardian Pharmacy Services Inc is a differentiated pharmacy services company that provides an extensive suite of technology-enabled services designed to help residents of LTCFs adhere to their appropriate drug regimen, which in turn helps reduce the cost of care and improve clinical outcomes. The company emphasizes high-touch, individualized clinical, drug dispensing, and administration capabilities that are tailored to serve the needs of residents in historically lower acuity LTCFs, such as ALFs and BHFs. The operating segment derives its revenues through sales of pharmaceutical and medical products, and all revenues are derived solely in the United States.